Eculizumab
Search results
Scope
Date
~
-
Bio & Pharma
Samsung Bioepis leads in Soliris biosimilar market in Europe
STOCKHOLM – Samsung Bioepis Co.'s biosimilar to Soliris for the treatment of patients with rare, life-threatening disease paroxysmal nocturnal...
May 27, 2024 (Gmt+09:00)
1